SCHEMBL30615249

SCHEMBL30615249

Cc1c(Cc2cccc(N)c2F)c(=O)oc2c(F)c(O)ccc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SHBG P04278 1/20 0.51
GAA P10253 3/20 0.50
KDM4E B2RXH2 2/20 0.50
JAK2 O60674 1/20 0.50
POLB P06746 1/20 0.50
MAPT P10636 1/20 0.50
PKM P14618 1/20 0.50
MAPK1 P28482 1/20 0.50
MPI P34949 1/20 0.50
HTT P42858 1/20 0.50
BLM P54132 1/20 0.50
MCL1 Q07820 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
ESR1 P03372 3/20 0.49
ESR2 Q92731 3/20 0.49
RAF1 P04049 5/20 0.42
MAP2K1 Q02750 5/20 0.42
ALDH1A1 P00352 1/20 0.42
GLA P06280 1/20 0.42
HPGD P15428 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26613773 1.00 SHBG (0.51) SHBGGAAKDM4EJAK2POLB
SCHEMBL26613704 0.83 SHBG (0.47) SHBGGAAKDM4EJAK2POLB
SCHEMBL30615239 0.83 SHBG (0.47) SHBGGAAKDM4EJAK2POLB
SCHEMBL959639 0.81 HSD17B3 (0.61) GAAKDM4EMAPTESR1ESR2
SCHEMBL960743 0.80 MAP2K1 (0.53) GAAKDM4EPOLBMAPTSMN1; SMN2
SCHEMBL26613695 0.77 RAF1 (0.42) GAAKDM4EPOLBHTTSMN1; SMN2
SCHEMBL30615238 0.77 RAF1 (0.42) GAAKDM4EPOLBHTTSMN1; SMN2
SCHEMBL965394 0.76 MAP2K1 (0.47) GAAKDM4ESMN1; SMN2RAF1MAP2K1
SCHEMBL30615232 0.72 MAP2K1 (0.44) GAAKDM4ESMN1; SMN2RAF1MAP2K1
SCHEMBL26613808 0.72 MAP2K1 (0.44) GAAKDM4ESMN1; SMN2RAF1MAP2K1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4701735-A1 HETEROCYCLIC DERIVATIVE AS MITOGEN-ACTIVATED PROTEIN KINASE (MEK) INHIBITOR Nested Therapeutics, Inc. (US) 2026-03-04 EP disclosed
EP-4514471-A1 HETEROCYCLIC DERIVATIVES AS MITOGEN-ACTIVATED PROTEIN KINASE (MEK) INHIBITORS Nested Therapeutics, Inc. (US) 2025-03-05 EP disclosed
CN-119487021-A Heterocyclic derivatives as inhibitors of mitogen-activated protein kinase (MEK) 内斯特治疗公司 2025-02-18 CN disclosed
WO-2024226579-A9 HETEROCYCLIC DERIVATIVE AS MITOGEN-ACTIVATED PROTEIN KINASE (MEK) INHIBITOR NESTED THERAPEUTICS, INC. (US) 2024-12-26 WO disclosed
WO-2024226579-A1 HETEROCYCLIC DERIVATIVE AS MITOGEN-ACTIVATED PROTEIN KINASE (MEK) INHIBITOR NESTED THERAPEUTICS, INC. (US) 2024-10-31 WO disclosed
WO-2023211812-A1 HETEROCYCLIC DERIVATIVES AS MITOGEN-ACTIVATED PROTEIN KINASE (MEK) INHIBITORS NESTED THERAPEUTICS, INC. (US) 2023-11-02 WO disclosed